Vif-APOBEC3G antagonists (University of Miami/University of California San Diego)

N/A

Report date: 2025/01/26 15:47:16
NME

Base Information

Drug NameVif-APOBEC3G antagonists (University of Miami/University of California San Diego)
Drug Alias NameVif-APOBEC3G antagonists (University of Miami)RN-18
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVirion infectivity factor inhibitorsAPOBEC3G deaminase inhibitors
TargetsVirion infectivity factorAPOBEC3G deaminase
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Miami
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of CaliforniaUniversity Of MiamiUniversity Of California San Diego
Inactive CompaniesN/A
Active IndicationsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A